Universitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2010

  1. The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly

    Journal of Clinical Endocrinology and Metabolism, Vol. 95, Núm. 1, pp. 222-229